Log In
Saturday 24th March 2018

Breast cancer drug launched

13th June 2008

Lapatinib, a drug used to extend the lives of women with HER2 positive breast cancer, has been made available by private prescription in the UK.

The drug is used to treat women in the advanced stages of the disease when Herceptin stops being able to treat the cancer. The National Institute for Health and Clinical Excellence has said it will review the drug before it decides if it will be made available on the health service.


Share this page


There are no comments for this article, be the first to comment!

Post your comment

Only registered users can comment. Fill in your e-mail address for quick registration.

Your email address:

Your comment will be checked by a Healthcare Today moderator before it is published on the site.

Mayden - Innovative cloud-based web development for the healthcare sector
© Mayden Foundation 2018